Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Stewart

Showing results (1131-1140 of 1,171) with videos related to

Pageof 118
Sort By:
Nature Medicine|June 6, 2024
Oncolytic adenoviral therapy plus pembrolizumab in BCG-unresponsive non-muscle-invasive bladder cancer: the phase 2 CORE-001 trialRoger Li, Paras H Shah, Tyler F Stewart, et al.
The Lancet. Oncology|October 3, 2006
Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trialAmar Gajjar, Murali Chintagumpala, David Ashley, et al.
Nature Communications|September 14, 2019
A novel role for the actin-binding protein drebrin in regulating opiate addictionJennifer A Martin, Craig T Werner, Swarup Mitra, et al.
Nature Communications|July 30, 2022
Maladaptive positive feedback production of ChREBPβ underlies glucotoxic β-cell failureLiora S Katz, Gabriel Brill, Pili Zhang, et al.
Biorxiv : the Preprint Server for Biology|September 30, 2024
Hippocampal γCaMKII dopaminylation promotes synaptic-to-nuclear signaling and memory formationAndrew F Stewart, Sasha L Fulton, Romain Durand-de Cuttoli, et al.
Neuro-Oncology|February 25, 2021
A phase II trial of selumetinib in children with recurrent optic pathway and hypothalamic low-grade glioma without NF1: a Pediatric Brain Tumor Consortium studyJason Fangusaro, Arzu Onar-Thomas, Tina Young Poussaint, et al.
Cell Reports|November 8, 2023
Integration of transcriptomes of senescent cell models with multi-tissue patient samples reveals reduced COL6A3 as an inducer of senescenceRadoslav Savić, Jialiang Yang, Simon Koplev, et al.
Science (New York, N.Y.)|April 11, 2020
Dopaminylation of histone H3 in ventral tegmental area regulates cocaine seekingAshley E Lepack, Craig T Werner, Andrew F Stewart, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 15, 2015
Vismodegib Exerts Targeted Efficacy Against Recurrent Sonic Hedgehog-Subgroup Medulloblastoma: Results From Phase II Pediatric Brain Tumor Consortium Studies PBTC-025B and PBTC-032Giles W Robinson, Brent A Orr, Gang Wu, et al.
Neuro-Oncology Advances|May 25, 2022
Phase I study of ribociclib and everolimus in children with newly diagnosed DIPG and high-grade glioma: A CONNECT pediatric neuro-oncology consortium reportMariko DeWire, Margot Lazow, Olivia Campagne, et al.
Pageof 118

Showing results (1131-1140 of 1,171) with videos related to

Sort By:
Pageof 118
Nature Medicine|June 6, 2024
Oncolytic adenoviral therapy plus pembrolizumab in BCG-unresponsive non-muscle-invasive bladder cancer: the phase 2 CORE-001 trialRoger Li, Paras H Shah, Tyler F Stewart, et al.
The Lancet. Oncology|October 3, 2006
Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trialAmar Gajjar, Murali Chintagumpala, David Ashley, et al.
Nature Communications|September 14, 2019
A novel role for the actin-binding protein drebrin in regulating opiate addictionJennifer A Martin, Craig T Werner, Swarup Mitra, et al.
Nature Communications|July 30, 2022
Maladaptive positive feedback production of ChREBPβ underlies glucotoxic β-cell failureLiora S Katz, Gabriel Brill, Pili Zhang, et al.
Biorxiv : the Preprint Server for Biology|September 30, 2024
Hippocampal γCaMKII dopaminylation promotes synaptic-to-nuclear signaling and memory formationAndrew F Stewart, Sasha L Fulton, Romain Durand-de Cuttoli, et al.
Neuro-Oncology|February 25, 2021
A phase II trial of selumetinib in children with recurrent optic pathway and hypothalamic low-grade glioma without NF1: a Pediatric Brain Tumor Consortium studyJason Fangusaro, Arzu Onar-Thomas, Tina Young Poussaint, et al.
Cell Reports|November 8, 2023
Integration of transcriptomes of senescent cell models with multi-tissue patient samples reveals reduced COL6A3 as an inducer of senescenceRadoslav Savić, Jialiang Yang, Simon Koplev, et al.
Science (New York, N.Y.)|April 11, 2020
Dopaminylation of histone H3 in ventral tegmental area regulates cocaine seekingAshley E Lepack, Craig T Werner, Andrew F Stewart, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 15, 2015
Vismodegib Exerts Targeted Efficacy Against Recurrent Sonic Hedgehog-Subgroup Medulloblastoma: Results From Phase II Pediatric Brain Tumor Consortium Studies PBTC-025B and PBTC-032Giles W Robinson, Brent A Orr, Gang Wu, et al.
Neuro-Oncology Advances|May 25, 2022
Phase I study of ribociclib and everolimus in children with newly diagnosed DIPG and high-grade glioma: A CONNECT pediatric neuro-oncology consortium reportMariko DeWire, Margot Lazow, Olivia Campagne, et al.
Pageof 118